36E79725Q0001_1.docx

Sources Sought Notice Sources Sought Notice

GENERAL INFORMATION

SET-ASIDE

CONTRACTING OFFICE ADDRESS

POINT OF CONTACT*

Contract Specialist Teresa Hussain teresa.hussain@va.gov 708-786-5852

PLACE OF PERFORMANCE

ADDRESS

POSTAL CODE

COUNTRY

ADDITIONAL INFORMATION

AGENCY’S URL

URL DESCRIPTION

AGENCY CONTACT’S EMAIL ADDRESS

EMAIL DESCRIPTION

DESCRIPTION

MARKET RESEARCH QUESTIONNAIRE – Metformin HCL SA Tablets Company Name: _________________________

I am conducting market research for the procurement of Metformin HCL SA Tabs for the Department of Veterans Affairs (VA), Department of Defense (DOD), Indian Health Service (IHS), Bureau of Prisons (BOP), and Federal Health Care Center (FHCC). This procurement will result in a national mandatory requirements contract for the above agencies. Other companies with the same/similar product will be blocked out for ordering; therefore, it is our goal to award lower than FSS/Open Market prices on the resultant national contract based on purchases of a committed volume. These products will be awarded in the aggregate by group for all strengths and sizes for the base year and all option years included in the solicitation. Please provide a response to the following:

1. Is your Company able to meet the following minimum requirements:

a. National Drug Code (NDC): Offerors shall provide a separate and distinct eleven-digit NDC number unique to the offeror (e.g., 00012-3456-78) for each product proposed. The first five numbers of the eleven-digit NDC number for each product proposed shall identify the offeror. Additionally, the successful offeror/contractor’s label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. All bottles of 400 tablets/capsules or less must have a safety-cap capable of having the outer part of the cap deshelled and / or a convertible cap to produce a non-safety cap child resistant closure. Does your company have a unique NDC (Labeler Code)?_____________

b. If the offeror is not the manufacturer of the offered items, the offeror shall submit a letter of commitment from the manufacturer to the offeror which will assure the offeror a source of supply sufficient to satisfy the Government's requirements for the contract period. Name of Manufacturer:_________________

Would you be able to provide a letter of commitment from the manufacturer of the offered drug?_____________

c. Pharmaceutical Prime Vendor: All Ordering Activities under the Department of Veterans Affairs and DOD acquire their pharmaceutical requirements through their Pharmaceutical Prime Vendor Programs (PPVs). The contractor shall ensure that chargeback agreements with the PPVs have been executed with sufficient time to permit the PPVs to begin timely distribution of Government orders if an award is made. For this procurement, all VA ordering will be for Group 2, Bulk through the Repackaging Program and OGAs (Group 1) will be through the PPVs. Does your company currently have a business-to-business agreement with the PPVs?_________

d. Under NAICS code 325412, is your company size (check one):

Large Business ______ Small Business ______

e. If a small business, does your company manufacture (measure, weigh, mix, and compound) at least 50% of the product offered?_________

f. Is the offered end-product U.S-made or an end product of a Trade Agreements Act designated country?_________

g. All OGA (Other Government Agency) requirements will go through the PPVs. All VA requirements will be purchased in bulk and go through the Pharmaceutical Repackager (currently Aphena Pharma Solutions). Groups 1 & 2 may be awarded separately for a possibility of two awards. Can your company meet the following product, bottle size and usage:

GROUP 1 - OGA

GROUP 2 - VA

QTY (Tabs) bulk

216,034,583

8,380,599

2 . Is your Company interested in submitting a response to a solicitation?________

3. As this is a national standardized contract, our preference is for a base plus four option years to provide our customers continuity and consistency of product by allowing long term committed purchases of your product. If interested, please indicate Base year and how many Option periods, not to exceed 4._________________

4. If an award were to be made based on the above requirements, would your company be able to begin supplying the product in the estimated quantities within 60 days of the contract award date (current contract expires 06/30/2025)?

5. If your company is not interested in participating, please respond with the reason why. This aids our market research for future procurements.

If you could provide your responses by next Thursday, October 17, 2024, it would be greatly appreciated. Please contact me if you have any questions.

Sources Sought Notice